Related Experiment Video

Updated: Sep 19, 2025

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

15.7K

Clinical progress note: Pneumococcal disease

Elizabeth L Nguyen1, Preeti Mehrotra2, Marie E Wang1

  • 1Division of Pediatric Hospital Medicine, Stanford University School of Medicine, Palo Alto, California, USA.

Journal of Hospital Medicine
|June 19, 2025
PubMed

Insights

Streptococcus pneumoniae causes serious illness, but pneumococcal vaccines have significantly reduced disease rates. Hospitalists are key in treating patients and ensuring vaccine eligibility.

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Public Health

Background:

  • Streptococcus pneumoniae is a major cause of preventable illness and death.
  • It causes diverse infections, from ear infections to meningitis.
  • Pneumococcal vaccines have drastically reduced disease incidence since 2000.

Purpose of the Study:

  • To highlight the impact of pneumococcal vaccines.
  • To emphasize the role of hospitalists in patient care and vaccination.

Main Methods:

  • Literature review on Streptococcus pneumoniae epidemiology.
  • Analysis of vaccine impact on disease trends.
  • Review of hospitalist responsibilities in infectious disease management.

Main Results:

  • Pneumococcal conjugate vaccine introduction led to significant declines in disease.
  • Vaccines are effective against a subset of over 100 serotypes.
  • Hospitalists are vital for treating pneumococcal infections and identifying vaccination needs.

Conclusions:

  • Pneumococcal vaccines are highly effective public health interventions.
  • Continued vigilance and vaccination efforts are essential.
  • Hospitalists play a critical role in managing pneumococcal disease and promoting vaccination.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.2K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
455
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
345
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
617
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
458
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K